TechInvention, Eubiologics collaborate to bring oral cholera vaccine to India

Published On 2021-03-29 05:00 GMT   |   Update On 2021-03-29 05:00 GMT

New Delhi: TechInvention Lifecare has tied up with South Korea-based biopharmaceutical firm Eubiologics Co Ltd for bringing in oral cholera vaccine 'Euvichol-Plus' to India. The vaccine is prequalified by the World Health Organization (WHO), TechInvention Lifecare Pvt Ltd said in a statement.

Eubiologics has so far supplied 55 million doses to UN healthcare agencies. Euvichol-Plus has been supplied to around 22 countries across the globe, it added.
"It is our endeavour to bring in a WHO prequalified oral cholera vaccine (OCV) in India for managing potential outbreak risk caused due to the often-neglected disease like cholera," TechInvention Founder and CEO Syed Ahmed said.
In a similar vein, Eubiologics Co CEO Yeong-Ok Baik said, "The collaboration between Eubiologics and Techinvention is aimed at reducing the disease burden and saving lives of Indian children by effective vaccination through our WHO-prequalified cholera vaccine, Euvichol-Plus in a unidose pack."




Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News